Skip to Content

eSURFACE 1 and reSURFACE 2: Biological therapy improves psoriasis and CVD

In this MEDtalk, Professor Nehal Mehta presents very interesting results from the reSURFACE 1 and 2 regarding the association between psoriasis and CVD and how both conditions improve following biological therapy with tildrakizumab.

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top